Targeting renal cell carcinoma Journal Article
| Authors: | Motzer, R. J.; Molina, A. M. |
| Article Title: | Targeting renal cell carcinoma |
| Keywords: | cancer survival; treatment outcome; treatment response; disease-free survival; vascular endothelial growth factor a; overall survival; clinical trial; sorafenib; bevacizumab; sunitinib; advanced cancer; drug safety; antineoplastic agents; benzenesulfonates; pyridines; note; alpha interferon; cancer patient; disease free survival; antineoplastic agent; progression free survival; randomized controlled trial; randomized controlled trials as topic; editorial; kidney carcinoma; kidney neoplasms; temsirolimus; kaplan-meiers estimate; blood; kidney tumor; carcinoma, renal cell; clinical trials, phase iii as topic; vasculotropin a; pazopanib; phase 3 clinical trial; kaplan meier method; axitinib; benzenesulfonic acid derivative; pyridine derivative |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 20 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-07-10 |
| Start Page: | 3274 |
| End Page: | 3276 |
| Language: | English |
| DOI: | 10.1200/jco.2009.21.8461 |
| PUBMED: | 19451422 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 2" - "Export Date: 30 November 2010" - "CODEN: JCOND" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
